In addition, ATM mutations were significantly more frequent in U-CLL compared to M-CLL (p < 0.001), in patients with advanced stage at diagnosis (p < 0.001) and in those eventually in need of treatment (p < 0.001, Table 2). This evidence concerns the gene ATM and B-cell chronic lymphocytic leukemia.